ECG Patch and Holter Monitor

Global ECG Patch and Holter Monitor Market to Reach US$5.4 Billion by 2030

The global market for ECG Patch and Holter Monitor estimated at US$1.9 Billion in the year 2024, is expected to reach US$5.4 Billion by 2030, growing at a CAGR of 19.6% over the analysis period 2024-2030. ECG Patch, one of the segments analyzed in the report, is expected to record a 17.9% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Holter Monitors segment is estimated at 22.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$487.2 Million While China is Forecast to Grow at 18.6% CAGR

The ECG Patch and Holter Monitor market in the U.S. is estimated at US$487.2 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$836.4 Million by the year 2030 trailing a CAGR of 18.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.8% and 17.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.

Global ECG Patch and Holter Monitor Market – Key Trends & Drivers Summarized

Are Wearables Redefining the Way Cardiac Health Is Monitored?

The emergence of ECG patches and modern Holter monitors is reshaping the cardiac diagnostics landscape, offering patients and clinicians more efficient, discreet, and data-rich alternatives to traditional cardiac monitoring. These compact, non-invasive devices allow continuous electrocardiogram recording over extended periods—ranging from 24 hours to several weeks—enabling early detection of arrhythmias, atrial fibrillation, and other heart abnormalities that often go unnoticed in clinical settings. The evolution from bulky, wire-laden monitors to lightweight, wireless ECG patches has dramatically improved patient compliance and comfort, especially for ambulatory and home-based monitoring. These developments have become especially critical given the global rise in cardiovascular disease, which remains the leading cause of mortality worldwide. As healthcare systems shift focus from episodic care to long-term condition management, continuous monitoring through wearable ECG technology has gained widespread adoption. Moreover, the increased emphasis on preventive healthcare, early detection, and remote care—amplified by the COVID-19 pandemic—has heightened demand for technologies that enable clinicians to monitor patients in real time, without requiring frequent hospital visits. ECG patches and Holter monitors now serve both diagnostic and post-treatment tracking purposes, streamlining patient care pathways and supporting better outcomes through real-time cardiac insights.

How Is Technology Elevating the Capabilities of ECG Monitoring Devices?

Technological innovation has significantly enhanced the performance, usability, and clinical relevance of ECG patch and Holter monitoring devices, enabling more accurate diagnostics and seamless integration into digital healthcare ecosystems. Key advancements include improved signal processing algorithms, miniaturization of components, cloud-based data storage, and AI-powered analytics that automatically detect and flag anomalies. These devices are no longer just recorders; they are real-time diagnostic tools capable of sending alerts directly to healthcare providers, empowering faster decision-making. With wireless communication capabilities, ECG patches can transmit data continuously to physicians, integrating with telehealth platforms and mobile apps for real-time feedback. Some patches now include additional biometric sensors, such as accelerometers and temperature monitors, which provide context for ECG data and enhance diagnostic precision. Furthermore, modern Holter monitors are designed with rechargeable batteries and extended wear times, reducing the need for repeated patient visits and increasing monitoring efficiency. Device interoperability with electronic health records (EHRs) has also improved, making it easier for clinicians to retrieve, analyze, and act on recorded data. These innovations are reducing diagnostic turnaround times, improving workflow efficiencies, and offering a more patient-friendly alternative to traditional cardiac testing modalities, positioning the technology at the forefront of connected care.

Are Changing Patient Expectations and Clinical Practices Reshaping Market Demand?

The shift toward personalized, home-based, and data-driven healthcare is playing a pivotal role in the rising adoption of ECG patches and Holter monitors. Today’s patients expect not only clinical accuracy but also comfort, convenience, and seamless digital interaction. This is particularly relevant in cardiac monitoring, where user compliance is essential to capturing reliable diagnostic data. Wearable patches, with their adhesive design and lack of external leads, have become especially popular among elderly patients and those requiring long-term monitoring. Meanwhile, physicians and healthcare providers are increasingly relying on continuous ambulatory ECG monitoring to make data-informed decisions for diagnosis, risk stratification, and therapy management—especially for conditions such as atrial fibrillation, syncope, or palpitations with uncertain origins. Healthcare systems are also embracing value-based care models, in which accurate and timely monitoring tools like ECG patches can prevent costly acute episodes and readmissions. In parallel, consumer-grade wearables like smartwatches have popularized heart health awareness, prompting more individuals to seek formal diagnostic tools for symptoms flagged by personal devices. Clinical workflows are adapting too, with cardiologists integrating remote monitoring solutions into outpatient settings, teleconsultations, and chronic care programs. As patient engagement becomes a strategic focus for providers, ECG patch and Holter monitor technologies are bridging the gap between clinical precision and everyday usability, redefining cardiac care delivery across the continuum.

What Is Powering the Rapid Growth of the ECG Patch and Holter Monitor Market?

The growth in the ECG patch and Holter monitor market is driven by several factors rooted in medical technology evolution, patient behavior, healthcare delivery models, and clinical requirements. Technological improvements—such as the miniaturization of components, longer battery life, Bluetooth-enabled connectivity, and AI-powered arrhythmia detection—have made these devices more functional, accessible, and user-friendly. On the clinical front, the rising global incidence of cardiovascular disorders like atrial fibrillation, bradycardia, and syncope has necessitated more widespread and prolonged cardiac monitoring, especially in aging populations. The shift toward remote monitoring and home-based diagnostics, supported by telehealth platforms, has also increased demand for wearable cardiac monitors that provide real-time data and early warning insights. Hospitals, clinics, and cardiology practices are adopting these solutions to reduce in-person follow-ups and optimize clinician workload. Additionally, consumer behavior is changing, with more patients seeking non-invasive, comfortable alternatives to traditional Holter monitors, particularly in outpatient or preventive care scenarios. Healthcare payers and insurance providers are further supporting adoption through favorable reimbursement for long-term monitoring in atrial fibrillation and other arrhythmias. Pharmaceutical companies and clinical research organizations are also employing ECG patches in trials to gather continuous cardiac safety data. Collectively, these drivers are shaping a high-growth environment for ECG patch and Holter monitor technologies, pushing the market toward greater innovation, higher adoption, and deeper integration into mainstream healthcare delivery.

SCOPE OF STUDY:

The report analyzes the ECG Patch and Holter Monitor market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (ECG Patch, Holter Monitors); Application (Diagnostics Application, Monitoring Application); End-Use (Hospitals & Clinics End-Use, Ambulatory Facilities End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

• AliveCor, Inc.
• Applied Cardiac Systems, Inc.
• Bardy Diagnostics, Inc.
• Biotricity Inc.
• Cardiac Insight Inc.
• GE HealthCare
• Hillrom (now part of Baxter International Inc.)
• iRhythm Technologies, Inc.
• Medtronic plc
• Midmark Corporation
• Nanowear, Inc.
• Philips Healthcare
• Preventice Solutions (a subsidiary of Boston Scientific)
• Qardio, Inc.
• ScottCare Corporation
• SmartCardia
• Spacelabs Healthcare
• Viatom Technology Co., Ltd.
• Vivalink, Inc.
• Wellysis Co., Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.